$DSS
DSS, INC. Stock $dss

$dss Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222032148 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$11.38M	$11.86M	$4.566M
YoY Change	61.26%	159.79%	23.87%
Cost Of Revenue	$9.810M	$11.37M	$3.184M
YoY Change	255.69%	257.04%	24.08%
Gross Profit	$1.570M	$494.0K	$1.382M
YoY Change	-63.48%	-64.25%	23.39%
Gross Profit Margin	13.8%	4.16%	30.27%
Selling, General & Admin	$11.05M	$14.68M	$5.600M
YoY Change	67.9%	162.09%	85.98%
% of Gross Profit	703.57%	2971.05%	405.21%
Research & Development	$551.0K	$331.0K	$190.0K
YoY Change	26.67%	74.21%	413.51%
% of Gross Profit	35.1%	67.0%	13.75%
Depreciation & Amortization	$3.574M	$2.926M	$740.0K
YoY Change	59.06%	295.41%	209.62%
% of Gross Profit	227.64%	592.31%	53.55%
Operating Expenses	$13.22M	$26.05M	$6.927M
YoY Change	36.0%	275.99%	87.57%
Operating Profit	-$11.65M	-$14.18M	-$5.545M
YoY Change	114.93%	155.78%	115.51%
Interest Expense	-$853.0K	$606.0K	-$3.079M
YoY Change	-88.05%	-119.68%	-139.7%
% of Operating Profit
Other Income/Expense, Net	-$601.0K	$3.627M	$325.0K
YoY Change	-340.4%	1016.0%
Pretax Income	-$30.33M	-$24.80M	-$8.299M
YoY Change	146.48%	198.84%	-260.15%
Income Tax	$172.0K		-$1.624M
% Of Pretax Income
Net Earnings	-$26.93M	-$24.80M	-$6.598M
YoY Change	124.33%	275.89%	-230.19%
Net Earnings / Revenue	-236.61%	-209.08%	-144.5%
Basic Earnings Per Share		-$0.15	-$0.19
Diluted Earnings Per Share	-$0.19	-$0.15	-$92.72K
COMMON SHARES
Basic Shares Outstanding	139.0M shares	139.0M shares	34.89M shares
Diluted Shares Outstanding		134.9M shares	34.89M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$46.59M	$22.85M	$69.14M
YoY Change	-17.68%	-66.96%	493.71%
Cash & Equivalents	$19.29M	$22.85M	$69.49M
Short-Term Investments	$27.30M
Other Short-Term Assets	$1.700M	$2.898M	$1.819M
YoY Change	-50.95%	59.32%	60.12%
Inventory	$7.721M	$8.663M	$3.535M
Prepaid Expenses
Receivables	$7.564M	$8.989M	$2.774M
Other Receivables	$11.72M	$12.27M	$19.72M
Total Short-Term Assets	$47.99M	$55.67M	$96.98M
YoY Change	-41.77%	-42.6%	445.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.39M	$16.07M	$13.09M
YoY Change	-82.04%	22.74%	214.79%
Goodwill	$60.92M	$56.61M
YoY Change	7.62%
Intangibles
YoY Change
Long-Term Investments	$162.0K	$1.326M	$36.65M
YoY Change	-99.38%	-96.38%	113.09%
Other Assets	$2.699M	$1.393M	$692.0K
YoY Change	451.94%	101.3%	-36.86%
Total Long-Term Assets	$200.9M	$209.2M	$122.1M
YoY Change	-0.73%	71.35%	90.1%
TOTAL ASSETS
Total Short-Term Assets	$47.99M	$55.67M	$96.98M
Total Long-Term Assets	$200.9M	$209.2M	$122.1M
Total Assets	$248.9M	$264.9M	$219.1M
YoY Change	-12.61%	20.91%	167.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.914M	$4.048M	$1.948M
YoY Change	208.02%	107.8%	38.94%
Accrued Expenses	$20.14M	$12.45M	$9.677M
YoY Change	-6.66%	28.61%	653.07%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$47.16M	$6.680M	$498.0K
YoY Change	1104.32%	1241.37%	90.8%
Total Short-Term Liabilities	$73.69M	$23.57M	$12.54M
YoY Change	164.96%	87.99%	180.49%
LONG-TERM LIABILITIES
Long-Term Debt	$10.18M	$50.16M	$6.664M
YoY Change	-81.73%	652.75%	119.14%
Other Long-Term Liabilities	$507.0K	$507.0K	$582.0K
YoY Change	-49.3%	-12.89%	-48.17%
Total Long-Term Liabilities	$10.69M	$50.67M	$7.246M
YoY Change	-81.15%	599.28%	74.02%
TOTAL LIABILITIES
Total Short-Term Liabilities	$73.69M	$23.57M	$12.54M
Total Long-Term Liabilities	$10.69M	$50.67M	$7.246M
Total Liabilities	$84.38M	$74.24M	$43.18M
YoY Change	-30.23%	71.94%	415.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$194.3M	-$167.4M
YoY Change	44.49%
Common Stock	$2.779M	$2.779M
YoY Change	74.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$125.6M	$152.5M	$175.9M
YoY Change
Total Liabilities & Shareholders Equity	$248.9M	$264.9M	$219.1M
YoY Change	-12.61%	20.91%	167.19%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$26.93M	-$24.80M	-$6.598M
YoY Change	124.33%	275.89%	-230.19%
Depreciation, Depletion And Amortization	$3.574M	$2.926M	$740.0K
YoY Change	59.06%	295.41%	209.62%
Cash From Operating Activities	-$3.702M	-$9.304M	-$2.154M
YoY Change	-207.74%	331.94%	9.01%
INVESTING ACTIVITIES
Capital Expenditures	$1.273M	-$553.0K	-$2.083M
YoY Change	-104.47%	-73.45%	10863.16%
Acquisitions
YoY Change
Other Investing Activities	$1.120M	-$10.85M	-$5.848M
YoY Change	-102.78%	85.55%	98.04%
Cash From Investing Activities	-$153.0K	-$11.40M	-$7.931M
YoY Change	-99.78%	43.79%	166.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	300.0K	-392.0K	13.93M
YoY Change	-99.43%	-102.81%	47.89%
NET CHANGE
Cash From Operating Activities	-3.702M	-9.304M	-2.154M
Cash From Investing Activities	-153.0K	-11.40M	-7.931M
Cash From Financing Activities	300.0K	-392.0K	13.93M
Net Change In Cash	-3.555M	-21.10M	3.842M
YoY Change	-72.42%	-649.19%	-14.03%
FREE CASH FLOW
Cash From Operating Activities	-$3.702M	-$9.304M	-$2.154M
Capital Expenditures	$1.273M	-$553.0K	-$2.083M
Free Cash Flow	-$4.975M	-$8.751M	-$71.00K
YoY Change	-115.6%	12225.35%	-96.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000771999
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges		usd
CY2021Q3	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges		usd
	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2022Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
CY2021Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
CY2022Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
CY2021Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
	DSS	Loss On Allowance For Obsolescence Of Inventory LossOnAllowanceForObsolescenceOfInventory		usd
	DSS	Change In Rou Assets And Lease Liabilities Net ChangeInRouAssetsAndLeaseLiabilitiesNet		usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
	DSS	Accretion Of Debt Discount Origination Fee And Prepaid Interest AccretionOfDebtDiscountOriginationFeeAndPrepaidInterest		usd
	DSS	Impairment Of Notes Receivable And Other Investments ImpairmentOfNotesReceivableAndOtherInvestments		usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt		usd
	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable		usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations		usd
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations		usd
	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations		usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
	DSS	Termination Of Right Of Use Lease Asset TerminationOfRightOfUseLeaseAsset		usd
	DSS	Termination Of Right Of Use Lease Liability TerminationOfRightOfUseLeaseLiability		usd
	DSS	Shares Received For Loan Origination Fee SharesReceivedForLoanOriginationFee		usd
	DSS	Shares Received For Prepaid Loan Interest SharesReceivedForPrepaidLoanInterest		usd
	DSS	Notes Receivable Converted To Equity Investments NotesReceivableConvertedToEquityInvestments		usd
	DSS	Shares Issued For Acquisition Of Marketable Securities SharesIssuedForAcquisitionOfMarketableSecurities		usd
	DSS	Shares Issued For Acquisition Of Notes Receivable SharesIssuedForAcquisitionOfNotesReceivable		usd
	DSS	Right Of Use Asset Addition RightOfUseAssetAddition		usd
	us-gaap	Stock Issued1 StockIssued1		usd
CY2021Q3	DSS	Revenue On Management Fee Income RevenueOnManagementFeeIncome		usd
	DSS	Revenue On Management Fee Income RevenueOnManagementFeeIncome		usd
CY2021Q3	DSS	Revenue On Net Investment Income RevenueOnNetInvestmentIncome		usd
	DSS	Revenue On Net Investment Income RevenueOnNetInvestmentIncome		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-32146
	dei	Entity Registrant Name EntityRegistrantName	DSS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	16-1229730
	dei	Entity Address Address Line1 EntityAddressAddressLine1	275 Wiregrass Pkwy
	dei	Entity Address City Or Town EntityAddressCityOrTown	West Henrietta
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	14586
	dei	City Area Code CityAreaCode	(585)
	dei	Local Phone Number LocalPhoneNumber	325-3610
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, $0.02 par value per share
	dei	Trading Symbol TradingSymbol	DSS
	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	139017172	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22845000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56595000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8989000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5673000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	8663000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	8261000	usd
CY2022Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	12273000	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	6310000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2898000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3466000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	55668000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	80305000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16065000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17674000	usd
CY2022Q3	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	55493000	usd
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	56374000	usd
CY2022Q3	us-gaap	Other Investments OtherInvestments	8190000	usd
CY2021Q4	us-gaap	Other Investments OtherInvestments	11001000	usd
CY2022Q3	us-gaap	Equity Method Investments EquityMethodInvestments	1326000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1080000	usd
CY2022Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	28083000	usd
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	14172000	usd
CY2022Q3	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1704000	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	5878000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1393000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	489000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8459000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	498000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	56606000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	56606000	usd
CY2022Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	31893000	usd
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	38630000	usd
CY2022Q3	us-gaap	Assets Assets	264880000	usd
CY2021Q4	us-gaap	Assets Assets	282707000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4048000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1920000	usd
CY2022Q3	DSS	Accrued Expenses And Deferred Revenue Current AccruedExpensesAndDeferredRevenueCurrent	11627000	usd
CY2021Q4	DSS	Accrued Expenses And Deferred Revenue Current AccruedExpensesAndDeferredRevenueCurrent	21180000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	396000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	402000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	819000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	393000	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	6680000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3916000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	23570000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	27811000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	50163000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	55711000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7991000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	120000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	507000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	880000	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.02
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.02
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	47000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	47000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2021Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2022Q3	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	0	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	139017172	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	139017172	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79745886	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79745886	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	2779000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1594000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	317125000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	294685000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-167417000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-134503000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	152487000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	161776000	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	30162000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	36409000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	182649000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	198185000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	264880000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	282707000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11862000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4566000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35927000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13218000	usd
CY2022Q3	DSS	Cost Of Revenue Exclusive Of Depreciation And Amortization CostOfRevenueExclusiveOfDepreciationAndAmortization	11368000	usd
CY2021Q3	DSS	Cost Of Revenue Exclusive Of Depreciation And Amortization CostOfRevenueExclusiveOfDepreciationAndAmortization	3406000	usd
	DSS	Cost Of Revenue Exclusive Of Depreciation And Amortization CostOfRevenueExclusiveOfDepreciationAndAmortization	27653000	usd
	DSS	Cost Of Revenue Exclusive Of Depreciation And Amortization CostOfRevenueExclusiveOfDepreciationAndAmortization	10045000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14677000	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6705000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	40316000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19164000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	26045000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	10111000	usd
	us-gaap	Operating Expenses OperatingExpenses	67969000	usd
	us-gaap	Operating Expenses OperatingExpenses	29209000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-14183000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5545000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-32042000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15991000	usd
CY2022Q3	DSS	Interest Income InterestIncome	319000	usd
CY2021Q3	DSS	Interest Income InterestIncome	1593000	usd
	DSS	Interest Income InterestIncome	613000	usd
	DSS	Interest Income InterestIncome	3130000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3627000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	325000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4203000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	575000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	606000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	31000	usd
	us-gaap	Interest Expense InterestExpense	2105000	usd
	us-gaap	Interest Expense InterestExpense	157000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	110000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	116000	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	344000	usd
CY2021Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1645000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	134000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2556000	usd
CY2022Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-14302000	usd
CY2021Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2996000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-10479000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-10894000	usd
	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	405000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24801000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8299000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39161000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25777000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1624000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4315000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-24801000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6675000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-39161000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-21462000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	2129000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-24801000	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-6675000	usd
	us-gaap	Profit Loss ProfitLoss	-39161000	usd
	us-gaap	Profit Loss ProfitLoss	-19333000	usd
CY2022Q3	DSS	Loss From Continuing Operations Attributed To Noncontrolling Interest LossFromContinuingOperationsAttributedToNoncontrollingInterest	4587000	usd
CY2021Q3	DSS	Loss From Continuing Operations Attributed To Noncontrolling Interest LossFromContinuingOperationsAttributedToNoncontrollingInterest	77000	usd
	DSS	Loss From Continuing Operations Attributed To Noncontrolling Interest LossFromContinuingOperationsAttributedToNoncontrollingInterest	6247000	usd
	DSS	Loss From Continuing Operations Attributed To Noncontrolling Interest LossFromContinuingOperationsAttributedToNoncontrollingInterest	336000	usd
CY2022Q3	DSS	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-20214000	usd
CY2021Q3	DSS	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-6598000	usd
	DSS	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-32914000	usd
	DSS	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-18997000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.78
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.78
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.08
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.08
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	134893360	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34888054	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102390079	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27203137	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	134893360	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34888054	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	102390079	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27203137	shares
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-39161000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-21462000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9351000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2075000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	74000	usd
	DSS	Equity Method Investments Gain Loss EquityMethodInvestmentsGainLoss	134000	usd
	DSS	Equity Method Investments Gain Loss EquityMethodInvestmentsGainLoss	-2556000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-10479000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-10894000	usd
	DSS	Loss On Allowance For Obsolescence Of Inventory LossOnAllowanceForObsolescenceOfInventory	326000	usd
	DSS	Change In Rou Assets And Lease Liabilities Net ChangeInRouAssetsAndLeaseLiabilitiesNet	-336000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	110000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	116000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4315000	usd
	DSS	Accretion Of Debt Discount Origination Fee And Prepaid Interest AccretionOfDebtDiscountOriginationFeeAndPrepaidInterest	-2287000	usd
	DSS	Gain On Sale Of Assets GainOnSaleOfAssets	405000	usd
	DSS	Impairment Of Notes Receivable And Other Investments ImpairmentOfNotesReceivableAndOtherInvestments	1899000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3316000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-829000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	728000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1580000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-568000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	277000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	904000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	25000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2128000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	432000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3205000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1808000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-379000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1054000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23251000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12448000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1349000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2816000	usd
	DSS	Payment To Acquire Real Estate PaymentToAcquireRealEstate	689000	usd
	DSS	Payment To Acquire Real Estate PaymentToAcquireRealEstate	6565000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	19026000	usd
	DSS	Purchase Of Marketable Securities PurchaseOfMarketableSecurities	14254000	usd
	DSS	Purchase Of Marketable Securities PurchaseOfMarketableSecurities	8789000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2557000	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	1235000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1276000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	9185000	usd
	DSS	Payments To Acquire Note Receivable Investments PaymentsToAcquireNoteReceivableInvestments	4687000	usd
	DSS	Payments To Acquire Note Receivable Investments PaymentsToAcquireNoteReceivableInvestments	24048000	usd
	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	786000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	180000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1115000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17816000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-53215000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	561000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1893000	usd
	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	6360000	usd
	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	7102000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	186000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1518000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	121737000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7317000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	126760000	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	207000	usd
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	3000000	usd
	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	3207000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-33750000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	64304000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56595000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5183000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22845000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	69487000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	198185000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17405000	usd
	DSS	Stock Issued During Period Value Stock Based Payments StockIssuedDuringPeriodValueStockBasedPayments	6220000	usd
	us-gaap	Profit Loss ProfitLoss	-39161000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	182649000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	76545000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	76545000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	121781000	usd
	DSS	Stock Issued During Period Value Stock Based Payments StockIssuedDuringPeriodValueStockBasedPayments	-2000	usd
	DSS	Stock Issued During Period Acquisition Of American Pacific Bancorp StockIssuedDuringPeriodAcquisitionOfAmericanPacificBancorp	20301000	usd
	us-gaap	Profit Loss ProfitLoss	-19333000	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	199292000	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	199292000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zgJjPY5zLuB5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_z7Nj9LkaA0j3">Use of Estimates</span> - </i></b>The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires the Company to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, the Company evaluates its estimates, including those related to the accounts receivable, convertible notes receivable, inventory, fair values of investments, intangible assets and goodwill, useful lives of intangible assets and property and equipment, fair values of options and warrants to purchase the Company’s common stock, preferred stock, deferred revenue and income taxes, among others. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84E_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z8RvArERAaK7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zc0tv9ieGG27">Reclassifications</span> </i></b>- Certain amounts on the accompanying consolidated balance sheets for the year ended December 31, 2021, have been reclassified to conform to current period presentation, as have certain amounts for the three and nine months ended September 30, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Inventory Adjustments InventoryAdjustments	434000	usd
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	388000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zbPwEfHxB7Td" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zVha77DggnLd">Concentration of Credit Risk</span> </i></b><i>-</i> The Company maintains its cash in bank deposit accounts, which at times may exceed federally insured limits. The Company believes it is not exposed to any significant credit risk as a result of any non-performance by the financial institutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the nine months ended September 30, 2022, one customer accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zgNtCo33OTk4">13</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of our consolidated revenue. As of September 30, 2022, this same customer accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zmqWI3yRXMl6">35% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of our consolidated trade accounts receivable balance. During the nine months ended September 30, 2021, this customer accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zjR0BwyfEnUj">31% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of our consolidated revenue and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zyVtpqtugY29">57% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of our consolidated trade accounts receivable balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2022, vendor 1 accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember_zOdS3pIUA9Tc">43%</span> and vendor 2 accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember_zPqWPGXE0fy5">21%</span> of our consolidated inventory purchases. As of September 30, 2021, vendor 1 accounted for <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember_zQ9fWxtVIXvc">76%</span> of our consolidated inventory purchases.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	42000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	20000	usd
	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	59684000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-7386000	usd
CY2022Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	52298000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	22845000	usd
CY2022Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	28083000	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P14Y10M24D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.043	pure
CY2022Q1	DSS	Royalty Percentage RoyaltyPercentage	0.055	pure
CY2022Q1	us-gaap	Development Costs DevelopmentCosts	1250000	usd
CY2022Q3	us-gaap	Investments Investments	1370000	usd
CY2021	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	73929000	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1544000	usd
CY2021Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	75473000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	56595000	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	14537000	usd
CY2021Q4	us-gaap	Investments Investments	4341000	usd
CY2021Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	6155000	usd
CY2021Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0425	pure
CY2021Q2	us-gaap	Debt Instrument Term DebtInstrumentTerm	P5Y
CY2021Q2	us-gaap	Debt Instrument Periodic Payment Terms Balloon Payment To Be Paid DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid	2829000	usd
CY2021Q4	us-gaap	Area Of Land AreaOfLand	40000	sqft
CY2021Q4	us-gaap	Area Of Land AreaOfLand	13.62	acre
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	79000	usd
CY2021Q2	us-gaap	Deferred Costs DeferredCosts	4821000	usd
CY2021Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	216000	usd
CY2021Q4	us-gaap	Debt Instrument Term DebtInstrumentTerm	P25Y
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	284000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1132000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	908000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	877000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	890000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	904000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	5768000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10763000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1953000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	8810000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	819000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7991000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	17570948	shares
	us-gaap	Interest Paid Net InterestPaidNet	1907000	usd
	us-gaap	Interest Paid Net InterestPaidNet	139000	usd
	DSS	Termination Of Right Of Use Lease Asset TerminationOfRightOfUseLeaseAsset	-744000	usd
	DSS	Termination Of Right Of Use Lease Liability TerminationOfRightOfUseLeaseLiability	744000	usd
	DSS	Shares Received For Loan Origination Fee SharesReceivedForLoanOriginationFee	3000000	usd
	DSS	Shares Received For Prepaid Loan Interest SharesReceivedForPrepaidLoanInterest	2440000	usd
	DSS	Notes Receivable Converted To Equity Investments NotesReceivableConvertedToEquityInvestments	1940000	usd
	DSS	Shares Issued For Acquisition Of Marketable Securities SharesIssuedForAcquisitionOfMarketableSecurities	7169000	usd
	DSS	Shares Issued For Acquisition Of Notes Receivable SharesIssuedForAcquisitionOfNotesReceivable	8717000	usd
	DSS	Right Of Use Asset Addition RightOfUseAssetAddition	9895000	usd
	us-gaap	Stock Issued1 StockIssued1	6216000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	5	segments
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11862000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2927000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	606000	usd
CY2022Q3	DSS	Interest Income InterestIncome	319000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-24801000	usd
CY2022Q3	DSS	Capital Expenditures CapitalExpenditures	373000	usd
CY2022Q3	DSS	Identifiable Assets IdentifiableAssets	264880000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4566000	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	739000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	31000	usd
CY2021Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	13000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1624000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6675000	usd
CY2021Q3	DSS	Capital Expenditures CapitalExpenditures	1640000	usd
CY2021Q3	DSS	Identifiable Assets IdentifiableAssets	219076000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35927000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9351000	usd
	us-gaap	Interest Expense InterestExpense	2105000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	4000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-39161000	usd
	DSS	Capital Expenditures CapitalExpenditures	1349000	usd
	DSS	Identifiable Assets IdentifiableAssets	264880000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13218000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2075000	usd
	us-gaap	Interest Expense InterestExpense	157000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	42000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4315000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-21462000	usd
	DSS	Capital Expenditures CapitalExpenditures	9381000	usd
	DSS	Identifiable Assets IdentifiableAssets	219076000	usd
CY2022Q3	DSS	Aggregate Value Of Printed Products AggregateValueOfPrintedProducts	5032000	usd
CY2021Q3	DSS	Aggregate Value Of Printed Products AggregateValueOfPrintedProducts	3416000	usd
	DSS	Aggregate Value Of Printed Products AggregateValueOfPrintedProducts	12650000	usd
	DSS	Aggregate Value Of Printed Products AggregateValueOfPrintedProducts	10652000	usd
CY2022Q3	DSS	Revenue On Direct Marketing RevenueOnDirectMarketing	4937000	usd
CY2021Q3	DSS	Revenue On Direct Marketing RevenueOnDirectMarketing	966000	usd
	DSS	Revenue On Direct Marketing RevenueOnDirectMarketing	17939000	usd
	DSS	Revenue On Direct Marketing RevenueOnDirectMarketing	2382000	usd
CY2022Q3	DSS	Revenue On Securities RevenueOnSecurities	1485000	usd
CY2021Q3	DSS	Revenue On Securities RevenueOnSecurities	184000	usd
	DSS	Revenue On Securities RevenueOnSecurities	4656000	usd
	DSS	Revenue On Securities RevenueOnSecurities	184000	usd
CY2022Q3	DSS	Revenue On Management Fee Income RevenueOnManagementFeeIncome	38000	usd
	DSS	Revenue On Management Fee Income RevenueOnManagementFeeIncome	38000	usd
CY2022Q3	DSS	Revenue On Net Investment Income RevenueOnNetInvestmentIncome	370000	usd
	DSS	Revenue On Net Investment Income RevenueOnNetInvestmentIncome	644000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	17570948	shares

Files In Submission

Name	View Source	Status
0001493152-22-032148-index-headers.html	Edgar Link	pending
0001493152-22-032148-index.html	Edgar Link	pending
0001493152-22-032148.txt	Edgar Link	pending
0001493152-22-032148-xbrl.zip	Edgar Link	pending
dss-20220930.xsd	Edgar Link	pending
ex1_001.jpg	Edgar Link	pending
ex1_002.jpg	Edgar Link	pending
ex1_003.jpg	Edgar Link	pending
ex1_004.jpg	Edgar Link	pending
ex1_005.jpg	Edgar Link	pending
ex1_006.jpg	Edgar Link	pending
ex1_007.jpg	Edgar Link	pending
ex1_008.jpg	Edgar Link	pending
ex1_009.jpg	Edgar Link	pending
ex1_010.jpg	Edgar Link	pending
ex1_011.jpg	Edgar Link	pending
ex1_012.jpg	Edgar Link	pending
ex1_013.jpg	Edgar Link	pending
ex1_014.jpg	Edgar Link	pending
ex1_015.jpg	Edgar Link	pending
ex1_016.jpg	Edgar Link	pending
ex1_017.jpg	Edgar Link	pending
ex1_018.jpg	Edgar Link	pending
ex1_019.jpg	Edgar Link	pending
ex1_020.jpg	Edgar Link	pending
ex1_021.jpg	Edgar Link	pending
ex1_022.jpg	Edgar Link	pending
ex1_023.jpg	Edgar Link	pending
ex1_024.jpg	Edgar Link	pending
ex1_025.jpg	Edgar Link	pending
ex1_026.jpg	Edgar Link	pending
ex1_027.jpg	Edgar Link	pending
ex1_028.jpg	Edgar Link	pending
ex1_029.jpg	Edgar Link	pending
dss-20220930_lab.xml	Edgar Link	unprocessable
dss-20220930_pre.xml	Edgar Link	unprocessable
ex1_030.jpg	Edgar Link	pending
ex1_031.jpg	Edgar Link	pending
ex1_032.jpg	Edgar Link	pending
ex1_033.jpg	Edgar Link	pending
ex1_034.jpg	Edgar Link	pending
ex1_035.jpg	Edgar Link	pending
ex1_036.jpg	Edgar Link	pending
ex1_037.jpg	Edgar Link	pending
ex1_038.jpg	Edgar Link	pending
ex1_039.jpg	Edgar Link	pending
ex1_040.jpg	Edgar Link	pending
ex1_041.jpg	Edgar Link	pending
ex1_042.jpg	Edgar Link	pending
ex1_043.jpg	Edgar Link	pending
ex1_044.jpg	Edgar Link	pending
ex1_045.jpg	Edgar Link	pending
ex1_046.jpg	Edgar Link	pending
ex1_047.jpg	Edgar Link	pending
ex1_048.jpg	Edgar Link	pending
ex1_049.jpg	Edgar Link	pending
ex1_050.jpg	Edgar Link	pending
ex1_051.jpg	Edgar Link	pending
ex1_052.jpg	Edgar Link	pending
ex1_053.jpg	Edgar Link	pending
ex1_054.jpg	Edgar Link	pending
ex1_055.jpg	Edgar Link	pending
ex1_056.jpg	Edgar Link	pending
ex1_057.jpg	Edgar Link	pending
ex1_058.jpg	Edgar Link	pending
ex1_059.jpg	Edgar Link	pending
ex1_060.jpg	Edgar Link	pending
ex1_061.jpg	Edgar Link	pending
ex1_062.jpg	Edgar Link	pending
ex1_063.jpg	Edgar Link	pending
ex2_001.jpg	Edgar Link	pending
ex2_002.jpg	Edgar Link	pending
ex2_003.jpg	Edgar Link	pending
ex2_004.jpg	Edgar Link	pending
ex2_005.jpg	Edgar Link	pending
ex2_006.jpg	Edgar Link	pending
ex2_007.jpg	Edgar Link	pending
ex2_008.jpg	Edgar Link	pending
ex2_009.jpg	Edgar Link	pending
ex2_010.jpg	Edgar Link	pending
ex2_011.jpg	Edgar Link	pending
ex2_012.jpg	Edgar Link	pending
ex2_013.jpg	Edgar Link	pending
ex2_014.jpg	Edgar Link	pending
ex2_015.jpg	Edgar Link	pending
ex2_016.jpg	Edgar Link	pending
ex2_017.jpg	Edgar Link	pending
ex2_018.jpg	Edgar Link	pending
ex2_019.jpg	Edgar Link	pending
ex2_020.jpg	Edgar Link	pending
ex2_021.jpg	Edgar Link	pending
ex2_022.jpg	Edgar Link	pending
ex2_023.jpg	Edgar Link	pending
ex3-1.htm	Edgar Link	pending
ex3-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
dss-20220930_cal.xml	Edgar Link	unprocessable
dss-20220930_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DSS
DSS, INC. Stock $dss

2022 Q4 Form 10-Q Financial Statement

#000149315222032148 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DSS DSS, INC. Stock $dss

2022 Q4 Form 10-Q Financial Statement

#000149315222032148 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DSS
DSS, INC. Stock $dss